Blog

Sharing Our Expertise

Lgm august feature image - lgm pharma
Overcoming API Challenges for Novel Drug Delivery Systems
The 505(b)(2) regulatory pathway is an increasingly popular method of getting drug approval – and one...
Read More >
Lgm july feature image 01 - lgm pharma
What Makes a Great CDMO Formulation Team?
 “Many people think all we do is mix things to make a product.” – Deepak Thassu, LGM’s...
Read More >
June 2021 - lgm pharma
The Impact of COVID-19 on Pharma Markets
The pandemic has left a substantial impact on our world that will be felt for years to come. It has led...
Read More >
May 2021 - lgm pharma
Why a CDMO Might Be the Best Place to Find Regulatory Support
The main goal for any drug company is achieving a speedy path to market. While many obstacles threaten...
Read More >
April 2021 - lgm pharma
Don’t Ignore the Market Opportunities of Oral Liquid Dosage Forms
Although solid dosage forms like tablets and capsules continue to dominate the global pharmaceutical...
Read More >
March 2021 - lgm pharma
Reshoring Early-Stage Pharma
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >